These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15966558)

  • 1. Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications.
    Pelusi C; Pasquali R
    Treat Endocrinol; 2003; 2(4):215-30. PubMed ID: 15966558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome update in adolescence.
    Hassan A; Gordon CM
    Curr Opin Pediatr; 2007 Aug; 19(4):389-97. PubMed ID: 17630601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-sensitizing agents in polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome.
    Kahn JA; Gordon CM
    Adolesc Med; 1999 Jun; 10(2):321-36. PubMed ID: 10370713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New adolescent polycystic ovary syndrome perspectives.
    Alemzadeh R; Kansra AR
    Minerva Pediatr; 2011 Feb; 63(1):35-47. PubMed ID: 21311428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome.
    Bayram F; Unluhizarci K; Kelestimur F
    Treat Endocrinol; 2002; 1(1):45-53. PubMed ID: 15765620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome.
    Diamanti-Kandarakis E; Zapanti E
    Ann N Y Acad Sci; 2000; 900():203-12. PubMed ID: 10818407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatments for polycystic ovary syndrome.
    Radosh L
    Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome in adolescents: current and future treatment options.
    Mastorakos G; Lambrinoudaki I; Creatsas G
    Paediatr Drugs; 2006; 8(5):311-8. PubMed ID: 17037948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent polycystic ovary syndrome.
    Connor EL
    Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome in pediatric obesity and diabetes.
    Dondi E; Tufano M; Vigone MC; Lucaccioni L; Pozzobon G; Ubertini G; Mozzillo E; Delvecchio M
    Minerva Pediatr (Torino); 2021 Dec; 73(6):523-536. PubMed ID: 34286948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which treatment options should be used in adolescents with polycystic ovary syndrome?
    Villa P; Di Sebastiano F; Rossodivita A; Sagnella F; Barini A; Fulghesu AM; Lanzone A
    J Pediatr Endocrinol Metab; 2004 May; 17(5):705-10. PubMed ID: 15237703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E; Grzyb K; Jainta N
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.